Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Rats had lasting erectile problems after stopping a certain medication.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Certain drugs change freshwater snail shells to a "banana" shape.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Some dibenzo compounds might help treat cancer with fewer side effects.

Finasteride reduces movement issues in Parkinson's disease rats.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Some herbs show promise as antiandrogenic agents.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.